Profil
Trevor Langley is the founder of KWS BioTest Ltd., where he holds the title of Managing Director starting in 2004.
He is currently working as a Non-Executive Director at Fixed-Phage Ltd.
Aktive Positionen von Trevor Langley
Unternehmen | Position | Beginn |
---|---|---|
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Gründer | 01.01.2004 |
Fixed-Phage Ltd.
Fixed-Phage Ltd. Medical/Nursing ServicesHealth Services Fixed-Phage Ltd. provides research for treatment and prevention of infection and bacterial contamination. The firm is engaged in developing and commercializing bacteriophage immobilization and stabilization technology. The company was founded by Mike Mattey and is headquartered in Glasgow, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
KWS BioTest Ltd.
KWS BioTest Ltd. Pharmaceuticals: MajorHealth Technology KWS BioTest Ltd. provides preclinical pharmacology and drug development for human diseases. Its capabilities include clinical biomarkers, cell biology, bioanalytical services, in vivo pharmacology, vaccine development. The company was founded by Williams A. Neil and Trevor Langley in 2004 and is headquartered in Bristol, the United Kingdom. | Health Technology |
Fixed-Phage Ltd.
Fixed-Phage Ltd. Medical/Nursing ServicesHealth Services Fixed-Phage Ltd. provides research for treatment and prevention of infection and bacterial contamination. The firm is engaged in developing and commercializing bacteriophage immobilization and stabilization technology. The company was founded by Mike Mattey and is headquartered in Glasgow, the United Kingdom. | Health Services |